SB 532 requires Maryland public senior colleges (like University System institutions) and community colleges to provide students with access to all over-the-counter contraception methods (such as condoms or emergency contraception) on campus through health centers, retail stores, or vending machines. Starting September 1, 2026, these institutions must submit annual reports to the Maryland Higher Education Commission detailing how access is provided, whether all methods are available, quantities distributed, and student consultation efforts. The Commission then reports this aggregated data to the Maryland General Assembly annually by October 1. The bill applies specifically to community colleges and public senior institutions (excluding specialized units like the University of Maryland Center for Environmental Science), effective July 1, 2026.
HB 1249 prohibits certified recovery residences in Maryland from refusing services to individuals receiving medication-assisted treatment (MAT) for opioid use disorder or requiring them to stop or change their MAT as a condition for housing. The bill amends certification standards for recovery residences (which provide non-clinical housing for people with substance use disorders) to ensure credentialing entities cannot allow such discrimination. It directly affects certified recovery residences and individuals using MAT for opioid addiction, requiring certification rules to explicitly ban these practices. The law takes effect October 1, 2026, and applies only to opioid use disorder treatment under MAT.
HB 1076 requires all public senior higher education institutions (like University System of Maryland schools) and community colleges in Maryland to annually report on student access to over-the-counter contraception to the Maryland Higher Education Commission. Community colleges must provide students with access to all FDA-approved over-the-counter contraception methods through campus health centers, retail locations, vending machines, or other accessible campus channels. Institutions must submit reports detailing access methods, availability, and student consultation, with the Commission then reporting aggregated data to the General Assembly each year. This bill directly affects campus health services and student access at public colleges, effective July 1, 2026.
HB 882 repeals the requirement that the Governor must include a mandatory $350,000 annual appropriation for the State's Consumer Health Information Hub in the budget. It also removes the automatic expiration date (June 30, 2026) for the Hub's funding provisions. The bill changes the Hub's mandate to carry out its duties "to the extent funding is available," meaning its operations now depend on annual budget decisions rather than guaranteed funding. This directly affects the Hub - designated as the University of Maryland Herschel S. Horowitz Center for Health Literacy - by eliminating its guaranteed funding stream and making its services subject to yearly budget approvals.
HB 372 requires hospitals with emergency departments to screen patients for emergency pregnancy-related medical conditions (defined as acute conditions posing serious health risks if untreated). If such a condition is identified, hospitals must provide treatment to stabilize the patient - including allowing pregnancy termination when medically necessary - or transfer the patient to another facility. The bill prohibits hospitals from penalizing healthcare providers who refuse to transfer unstable patients or from taking adverse action against staff who report violations. It directly affects hospitals, patients with emergency pregnancy conditions, and healthcare providers treating these cases, with fines up to $50,000 for non-compliance.
HB 457 requires all Maryland colleges and universities to provide free tampons and pads in every restroom by August 1, 2028. This applies to every public and private institution of higher education in the state, directly affecting students, staff, and faculty who use campus restrooms. The bill mandates that institutions supply size-appropriate products without cost, ensuring accessibility for individuals who menstruate. The requirement takes effect July 1, 2026, with full implementation due by the 2028 deadline.
This bill requires Maryland hospitals to screen patients in emergency departments for pregnancy-related medical emergencies. If a patient has such a condition, hospitals must stabilize it through appropriate treatment - including pregnancy termination when medically necessary - before transferring them, and cannot transfer unstable patients without following federal emergency transfer rules. It prohibits hospitals from retaliating against staff who refuse transfers of unstable patients or report violations, and imposes civil penalties (up to $50,000) for noncompliance. The law applies to all Maryland hospitals and aims to ensure timely, stable care for pregnant patients in medical crises.
HB 625 shifts responsibility for collecting fees from research facilities to the Maryland Department of Agriculture, replacing the current system under the Department of Health. It requires facilities submitting USDA Form 7023 (for animal testing) to pay annual contributions based on animal count: $5,000 for ≤100 animals, $10,000 for 101-500, $55,000 for 501-5,000, and $75,000 for over 5,000. Funds collected will support the Human-Relevant Research Fund established under Maryland’s Economic Development Article. The bill repeals existing health code provisions and creates new agriculture code sections for this fee structure, effective October 2026.
HB 1109 creates the Maryland Medical Reserve Corps, a statewide volunteer network for emergencies like disease outbreaks or disasters, managed by the Maryland Department of Health. It requires the Department to notify county health officers about procurement opportunities for electronic health records systems, allowing counties to join without state approval if fully funded locally. The bill establishes a Public Health Workforce Development Fund (using interest earnings and transfers from another fund) and mandates the Department of Legislative Services to assess health equity impacts of new legislation. These changes directly affect county health departments, the Department of Health, and public health workforce planning.
HB 1533 (the Crown and Care Act) bans 12 specific harmful ingredients - including certain phthalates, formaldehyde, mercury, and PFAS chemicals - from cosmetic products sold in Maryland. It directly affects cosmetic manufacturers, retailers, and salons by prohibiting the sale or distribution of products containing these ingredients, with limited exceptions for unavoidable trace amounts from manufacturing processes. The bill authorizes the Maryland Department of Health to investigate complaints, inspect businesses, and enforce penalties, while allowing consumers harmed by violations to seek civil damages and attorney fees. This law aims to protect public health by reducing exposure to chemicals linked to health risks like skin irritation and potential long-term harm.
